chrisvoncsefalvay/vaers-outcomes huggingface dataset:
No additional AE details available; healthcare professional in charge of vaccine storage calling for evaluation on refrigerated products that occurred 9/5/2022. Products were administered to multiple patients. Healthcare professional provides initials for all patients involved.  Names of vaccines involved (including lot/e; This spontaneous report was received from a healthcare professional and refers to a patient of unknown age and gender. Concomitant therapies included sterile diluent. There was no information about the patient's concurrent conditions, drug reactions, allergies or medical history provided.  On 06-SEP-2022, the patient was administered a dose of improperly stored measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (recombinant human albumin [rHA]) (M-M-R II) subcutaneous injection, lot # U031360 was confirmed to be valid, with expiration date 07-OCT-2023, for prophylaxis (exact dose, route of administration and anatomical site were not provided) (product storage error). The vaccine was improperly stored for 8 hours in the temperature above 46 degrees Fahrenheit (F) (62.8 F). It was unknown if data logger was used to capture the temperature excursion. There was no previous temperature excursion. No additional adverse event details were available (no adverse event).; Sender's Comments:  US-009507513-2209USA002722:02242097 US-009507513-2209USA002779:02242131 US-009507513-2209USA003055:02242082 US-009507513-2209USA002510:02242136 US-009507513-2209USA002557:02242137 US-009507513-2209USA002540:02242138 US-009507513-2209USA002566:02242139 US-009507513-2209USA002746:02242132 US-009507513-2209USA002481:02242135 US-009507513-2209USA002745:02242092 US-009507513-2209USA002570:02242096 US-009507513-2209USA002574:02242099 US-009507513-2209USA002469:02242101 US-009507513-2209USA002559:02242113 US-009507513-2209USA002573:02242103 US-009507513-2209USA002606:02242106 US-009507513-2209USA002532:02242109
Loss of taste and smell. I have a very unpleasant taste and smell to where everything smells the same and everything tastes the same. At first everything was just faint, but as days have gone on it has gotten worse and I can no longer taste or smell anything (much like when I had COVID in January).
2 days after my 1st vaccine (Thursday, 3/4), I started to feel a slight shortness of breath...it was not severe but felt pretty constant regardless if I was still or moving...not a full catching of breath but the sensation was there  I went to Urgent Care on Friday 3/5 to get tested for COVID, and that came back negative on Rapid (3/5) and PCR (3/7)  The symptom continued into Monday 3/8, and I went back to Urgent Care to get a Chest X-Ray and Blood work.  The Chest X Ray came back normal, but the D Dimer showed an elevated level and they recommended I go get a CT Scan to check for Blood Clots  I went to ER to get a CT Scan with Contrast, which came back clean.  They also did a ECG 12 Lead and Troponin I Test, all came back clean  I was discharged on 3/8, with Hospital potentially diagnosing the issue as Pluerisy.  This could be from a common cold, but also concerned that the vax caused some internal inflammation   Still feeling the sensation on 3/9, have a follow up appointment with GP on Friday 3/12 to go over all tests
Information has been received from a registered nurse concerning a 29 year old patient of unknown gender, who on 27-AUG-2012 was vaccinated with a dose of M-M-R II 0.5 ml, SQ, rHA, lot # (667246/0907Z) that had expired on 09-JUL-2012. No adverse effects reported. Additional information has been requested.
Rash on the neck; This spontaneous case was reported by a patient and describes the occurrence of RASH (Rash on the neck) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (Rash on the neck). At the time of the report, RASH (Rash on the neck) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant product use was reported. No treatment details were provided.
No additional AE reported; a patient received an expired dose of VARIVAX; This spontaneous report as received from a medical assistant refers to a 12-month-old male patient.  The patient's concurrent conditions, medical history, and concomitant medications were not reported.  On 23-DEC-2021, the patient was vaccinated with the first dose of varicella virus vaccine live (oka/merck) (VARIVAX) (Lot # S038700, expiration date: 01-DEC-2021) (Expired product administered) 1 dose in the right thigh for prophylaxis (exact dose, route of administration, and frequency were not reported).    After the vaccine was given it was discovered that it was expired. The medical assistant wanted to know if there is anything specific that they should be concerned about, and if the patient should be re-vaccinated. No other adverse events were associated with the patient. The medical assistant would like to be contacted for further information regarding revaccination.
Information has been received from a medical assistant concerning a 13 month old male who on 17-MAR-2009 was vaccinated with MMR II (lot # 660203/0452X) SC in the right leg and VARIVAX (Oka/Merck) (lot # 663299/1774X) by SC in the left leg. On 17-MAR-2009 the patient experienced hives at the injection site for both the MMR II and the VARIVAX (Oka/Merck) (WAES #0903USA05257). Subsequently, the patient recovered. The patient sought medical attention, spoke to physician. Additional information has been requested.
16 YRO Pt was administered Moderna vaccine approved for 18 >=YRO. Pt . Tolerated well. No adverse reaction noted. Pt. Returned for second dose on 05/12/2021 but was not administed the dose. Risk management is reviewing.
Found passed out inside car 5 mins post vaccination, c/o nausea, feeling tired when he came to senses, MD on site and CalMed responded, vital signs obtained @347PM, BP 93/62, pulse 67, 96% sats on room air. BSugar 86.  Standing blood pressure 107/69, normal sinus rhythm, rate 74. Agreed to be trasferred to Hospital via Fire Dept Ambulance at 411PM.
shingles; trouble breathing; didn't get 2nd dose; This case was reported by a consumer and described the occurrence of shingles in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and not applicable after receiving Shingles vaccine, the patient experienced shingles, difficulty breathing and incomplete course of vaccination. On an unknown date, the outcome of the shingles, difficulty breathing and incomplete course of vaccination were unknown.   It was unknown if the reporter considered the shingles and difficulty breathing to be related to Shingles vaccine.  Additional details were provided as follows: This case was reported by reporter for his/her father. The age at vaccination was not reported. The patient received dose and had adverse reaction (trouble breathing). The patient also experienced mild case of shingles. The patient didn't get the 2nd dose, which led to incomplete course of vaccination
cough; loss of appetite/ not eating; not eating; sick to stomach; dry heaves; tired; fell down stairs; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (cough), DECREASED APPETITE (loss of appetite/ not eating), EATING DISORDER (not eating), ABDOMINAL DISCOMFORT (sick to stomach) and RETCHING (dry heaves) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Cough.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced FALL (fell down stairs). On an unknown date, the patient experienced COUGH (cough), DECREASED APPETITE (loss of appetite/ not eating), EATING DISORDER (not eating), ABDOMINAL DISCOMFORT (sick to stomach), RETCHING (dry heaves) and FATIGUE (tired). At the time of the report, COUGH (cough), DECREASED APPETITE (loss of appetite/ not eating), EATING DISORDER (not eating), ABDOMINAL DISCOMFORT (sick to stomach), RETCHING (dry heaves), FALL (fell down stairs) and FATIGUE (tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. The patient received Norco after falling from stairs on 08-Feb-2021.
Pins and needles in arm; Feels like someone went in and tied a knot in ligament/feels like ligament is screwed down; Sore arm; A spontaneous report was received from a consumer concerning a an 67-year-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced sore arm ( vaccination site pain), pins and needles in arm  (paresthesia at vaccination site) and feels like someone went in and tied a knot in ligament/feels like ligament is screwed down (ligament sprain).  The patient's medical history was provided as controlled blood pressure,COVID-19 and hashimoto's disease,neuropathy after receiving some vaccines .The Concomitant medications were reported  as unknown medications for blood pressure.  On 11 Mar 2021 , approximately on the same day prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 022B21A)via unknown route in an unknown location  for prophylaxis of COVID-19 infection.   On the same day 11 Mar 2021 after receiving the vaccine, patient developed a sore arm. After two days, approximately on 14Mar2021patient developed neuropathy in the vaccinated arm. She still  has neuropathy. The patient described neuropathy as sensitivity in her inner arm from elbow to wrist, which restricted her from lifting her arm, swelling on inside of inner elbow, it feels like "someone went in and tied a knot in ligament", pins and needles in arm, feels like ligament is screwed down. The patient reported consulting her physical on 23 Mar 2021.  Action taken with mRNA-1273 in response to the events was not reported  The outcome of events were reported as not resolved.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Initially had some mild redness at vaccination site noted on 2/4/2021, this continued to worsen despite use of cold compress, Benadryl and Tylenol; was sent to Urgent Care on 2/7/2021 and diagnosed with Cellulitis; treated with a course of oral antibiotics
Recvd vax 26JAN93, started running temp; 27JAN 2-4AM temp 104, had uncontrollable, unconsolable crying; to ER-t105.9; wasn't admitted; tx unk; sx resolved w/in 24 hrs; got dose of APAP w/DPT & parent instructed to give another dose @ home;
No additional AE reported.; pregnant patient inadvertently received a dose of GARDASIL 9; This spontaneous prospective pregnancy report was received from a nurse and refers to a female patient of unknown age. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On unknown date in February 2023, the pregnant patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (formulation defaulted as injection, dose, anatomical location, lot # and expiration date were not reported) for prophylaxis. The last menstrual period (LMP) and estimated date of delivery (EDD) was not known. The pregnancy outcome was outcome pending. Fetal outcome was unknown. No additional adverse events were reported (exposure during pregnancy) (no adverse event).
Breakthrough case admission after 3 vaccines MOderna 3/7/21 lot# 030A21A;  Moderna 4/5/21 lot# 006B21A;  Moderna 12/10/21 lot# 013F21A;
This is a spontaneous report from a contactable consumer, the patient. A 42 years-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207) via an unspecified route administration in right arm on 20Mar2021 at 17:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medication taken within two weeks included vitamin D (MANUFACTURER UNKNOWN) from unknown date and for unknown indication. The patient did not have any allergies to food, medications, or other products. The patient did not receive any treatment for events stomach cramps and nausea. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. The patient did not receive any other vaccines within two weeks prior to the vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6203) via an unspecified route administration in left arm on 27Feb2021 at 17:30 (at the age of 42-years-old) as a single dose, for COVID-19 immunisation. On 21Mar2021, the patient experienced stomach cramps and nausea. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for events stomach cramps and nausea. The clinical outcome of the events stomach cramps and nausea was not recovered. No follow-up attempts are needed. No further information is expected.
Since my husband has had the vaccine he constantly has bad headaches and nausea.  NOT even a little bit had he anything close to this.  We are worried about this and I've been thinking and thinking as at our age and his leukemia it is scary.  He was worried enough that in the middle of moving to Fl from Ut he found a oncologist to make sure was not anything to do with cancer.  We can get the medical information concerning that visit if necessary but really getting concerned this is a temporary illness as been to long
On the day following immunization, patient came to the pharmacy reporting a reaction only in her right arm (PNEUMOVAX 23). Symptoms included redness, swelling, and stiffness of the arm. She felt feverish and experienced nausea and vomiting. Pharmacist on duty counseled the patient to go to a clinic if symptoms worsened but BENADRYL and ice could be utilized now for symptom reduction. Pharmacist called to check on patient later that evening, and she reported she was already improving. She decided not to go to a doctor. The administering pharmacist called to check on the patient on 1/3/19, and patient reported about 80% of the redness, swelling, and stiffness was already gone. She was still experiencing nausea (no vomiting), but had been taking some ZOFRAN she had on hand at home from a previous fill. When the pharmacist was discussing this with the patient, the patient profile was being viewed. Pharmacist noted patient had a ZOFRAN allergy listed on her profile. When pt was asked about this, she said she now does remember reporting an allergy to it, but cannot remember what the allergy was as she had had a stroke in  the past that interfered with her memory. Patient decided to stop taking ZOFRAN and take Meclizine OTC at recommendation of the pharmacist. Patient was appreciative of the call. Pharmacist listed 'Pneumococcal vaccine' as allergy under patient profile.
Lower back pain started the day after vaccine.  Not sure if even related to vaccine but wanted to know if others had this after effect.
familiar to a seizure; collapsed; unconscious; fever; shaking; they told possible sign of infection; This is a spontaneous report from a Pfizer sponsored program. A non-contactable consumer reported that a 14-year-old female patient (consumer's daughter) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), the second dose via unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The relevant medical history was not reported. Concomitant medications were not reported. On an unspecified date, after getting the second dose of the Covid Vaccine immediately started experiencing fever, shaking; her eyes were back as she seemed unconscious and collapsed; it was familiar to a seizure; was taken to the hospital, they told possible sign of infection and she was advised to go ahead and just to report what had happened. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Moderna bivalent vaccine was administered after a temperature excursion due to hurricane fiona and the vaccine was not visible.; No adverse event; Moderna bivalent vaccine was administered after a temperature excursion due to hurricane and the vaccine was not visible.; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna bivalent vaccine was administered after a temperature excursion due to hurricane and the vaccine was not visible.), POOR QUALITY PRODUCT ADMINISTERED (Moderna bivalent vaccine was administered after a temperature excursion due to hurricane and the vaccine was not visible.) and NO ADVERSE EVENT (No adverse event) in a 74-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. A57162B) for COVID-19 prophylaxis.     Concurrent medical conditions included Diabetes, Hypothyroidism and Hypertension.    On 03-Oct-2022 at 10:14 AM, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .5 milliliter. On 03-Oct-2022 at 10:14 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Moderna bivalent vaccine was administered after a temperature excursion due to hurricane and the vaccine was not visible.). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna bivalent vaccine was administered after a temperature excursion due to hurricane and the vaccine was not visible.) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna bivalent vaccine was administered after a temperature excursion due to hurricane and the vaccine was not visible.), POOR QUALITY PRODUCT ADMINISTERED (Moderna bivalent vaccine was administered after a temperature excursion due to hurricane and the vaccine was not visible.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna bivalent vaccine was administered after a temperature excursion due to hurricane and the vaccine was not visible.) and POOR QUALITY PRODUCT ADMINISTERED (Moderna bivalent vaccine was administered after a temperature excursion due to hurricane and the vaccine was not visible.).    It was reported as unknown that the patient had ever been diagnosed with tested positive for COVID-19.  No concomitant medications were reported.  The Moderna Bivalent vaccine was administered after a temperature excursion due to hurricane and the vaccine was not viable and no adverse events were reported.  No treatment medications were reported.
Red rash at site of injection starting one day later, lasting for 8 days. Swollen lymph nodes for 3 days after injection.
Patient was schedule to received dose#2 at 21 days after first dose. First dose 04/19/21. Patient cancelled appointment and re- self scheduled for 05/04/21. Vaccinator did not check vaccine record card and patient received second Pfizer Covid vaccine too early. Per CDC guidelines, dose was not repeated.
No additional AE reported; Patient was accidentally administered a third dose of VARIVAX; This spontaneous report was received from a nurse and refers to a 5 year old patient of unknown gender. The patient's concurrent conditions, medical history and concomitant medications were not reported.  On an unknown date, the patient was vaccinated with a first and a second dose of varicella virus vaccine live (oka/merck)(VARIVAX) (strength, lot #, expiration date, dose, route and frequency were not reported) for prophylaxis.       On 08-SEP-2021, the patient was accidentally administered a third dose of varicella virus vaccine live (oka/merck)(VARIVAX) 0.5 milliliter, lot # T027301, expiration date 12-AUG-2022 (route was not reported) for prophylaxis.        No adverse events were reported.
This spontaneous report was received from a pharmacist refers to an over 65 years old female patient. On 01-OCT-2013 (a week ago) the patient was vaccinated with ZOSTAVAX (dose, route and indication unknown). Concomitant medication included warfarin. Pharmacist reported that after the patient was administered ZOSTAVAX, "a week ago" (01-OCT-2013), the patient developed a "half dollar sized red mark" at the injection site "the next day". The pharmacist stated "the red mark turned into a bruise 5 days later (06-OCT-2013)". The pharmacist stated the patient saw her unspecified primary care provider on an unspecified date in regards to this reaction. At time of reporting, the patient had not recovered from the events. Additional information has been requested.
Information has been received from a registered nurse concerning a 23 year old  female patient, with allergies to penicillin, sulfa and ciprofloxacin hydrochloride, who on March 26, 2003 at 14:15 (previously reported as Mar 27, 2003) was vaccinated SC into the left upper arm with a second dose of MMR II (lot #644644/1080M). It was reported that the patient was not ill at the time of vaccination. No concomitant medications were reported. The patient received the first dose of MMR II on Aug 13, 1984. On March 28, 2003 (previously reported as March 27, 2003), the patient presented with local inflammation to the left upper arm with a red, raised lump on her arm at the injection site. The area was hot to touch and about 1in in diameter. the patient had no other symptoms. The patient denied itching and ice was applied. As of April 02, 2003 the local inflammation had subsided and the patient recovered. Unspecified medical attention was sought. Additional information is not expected.
On the day of the vaccine I got nauseous about 12:00. This lasted until bedtime.  Throughout the night I experienced chills, an earache and my skin was very sensitive to the touch. Upon rising about 9:00 those symptoms went away and I became nauseous again and my bones aches like I had the flu. Woke up the second day after the vaccine and I am completely well. It is like a switch gets turned off and your well again!!
The patient is a 70 y.o. female who presents to the  Emergency Department with vomiting that began 8 days ago. She reports that she has not been able to eat for a week and has no appetite. Denies pain in the abdomen. She has been vomiting every time she eats and also has not been able to tolerate fluids. Pt reports loose stools that are almost diarrhea. Denies dysuria. Pt has a hx of DM. Also reports cramping pain in her legs that is chronic and HTN. Pt denies hx of overnight hospitalizations. Denies smoking cigarettes, using drugs, or drinking alcohol. The pt has not been checking her blood sugars at all.